James George Robinson, Director at NYMOX PHARMACEUTICAL CORP (NYMX), bought 11,599 shares at $1.42 ($17K) on 2019-06-11, disclosed to the SEC on 2019-06-12.
Open-market purchase of $17k NYMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.42 | 882 | $1K | 7.4% |
| 2 | $1.42 | 1,430 | $2K | 12.0% |
| 3 | $1.42 | 200 | $284 | 1.7% |
| 4 | $1.42 | 1,430 | $2K | 12.0% |
| 5 | $1.42 | 882 | $1K | 7.4% |
| 6 | $1.43 | 700 |
| $1K |
| 5.9% |
| 7 | $1.44 | 1,100 | $2K | 9.4% |
| 8 | $1.45 | 1,300 | $2K | 11.2% |
| 9 | $1.47 | 100 | $147 | 0.9% |
| 10 | $1.48 | 900 | $1K | 7.9% |
| 11 | $1.49 | 500 | $745 | 4.4% |
| 12 | $1.51 | 701 | $1K | 6.3% |
| 13 | $1.52 | 400 | $608 | 3.6% |
| 14 | $1.53 | 200 | $306 | 1.8% |
| 15 | $1.54 | 300 | $462 | 2.7% |
| 16 | $1.60 | 287 | $459 | 2.7% |
| 17 | $1.60 | 287 | $459 | 2.7% |
| Total | $1.46 avg | 11,599 | $17K | 100% |
| Filing → |
| NYMX | BUY | 2022-05-06 | $3.8M | — | Filing → |
| NYMX | BUY | 2021-04-27 | $83K | — | Filing → |
| NYMX | BUY | 2019-07-12 | $12K | — | Filing → |